Global Small Molecule Active Pharmaceutical Ingredient Market Data Survey Report 2013-2025
Table of Contents
1 Global Market Overview
- 1.1 Scope of Statistics
- 1.1.1 Scope of Products
- 1.1.2 Scope of Manufacturers
- 1.1.3 Scope of Application
- 1.1.4 Scope of Type
- 1.1.5 Scope of Regions/Countries
- 1.2 Global Market Size
2 Regional Market
- 2.1 Regional Production
- 2.2 Regional Demand
- 2.3 Regional Trade
3 Key Manufacturers
- 3.1 Johnson Matthey
- 3.1.1 Company Information
- 3.1.2 Product & Services
- 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.1.4 Recent Development
- 3.2 Siegfried Holding AG
- 3.2.1 Company Information
- 3.2.2 Product & Services
- 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.2.4 Recent Development
- 3.3 Pfizer
- 3.3.1 Company Information
- 3.3.2 Product & Services
- 3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.3.4 Recent Development
- 3.4 Sanofi S.A.
- 3.4.1 Company Information
- 3.4.2 Product & Services
- 3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.4.4 Recent Development
- 3.5 Novartis AG,
- 3.5.1 Company Information
- 3.5.2 Product & Services
- 3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.5.4 Recent Development
- 3.6 Bristol-Myers Squibb
- 3.6.1 Company Information
- 3.6.2 Product & Services
- 3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.6.4 Recent Development
- 3.7 Boehringer Ingelheim GmbH
- 3.7.1 Company Information
- 3.7.2 Product & Services
- 3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.7.4 Recent Development
- 3.8 GlaxoSmithKline
- 3.8.1 Company Information
- 3.8.2 Product & Services
- 3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.8.4 Recent Development
- 3.9 Albany Molecular Research Inc.
- 3.9.1 Company Information
- 3.9.2 Product & Services
- 3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.9.4 Recent Development
- 3.10 Bachem Holding AG
- 3.10.1 Company Information
- 3.10.2 Product & Services
- 3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.10.4 Recent Development
- 3.11 PCAS
- 3.11.1 Company Information
- 3.11.2 Product & Services
- 3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.11.4 Recent Development
- 3.12 Patheon N.V.
- 3.12.1 Company Information
- 3.12.2 Product & Services
- 3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.12.4 Recent Development
- 3.13 AstraZeneca
- 3.13.1 Company Information
- 3.13.2 Product & Services
- 3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.13.4 Recent Development
- 3.14 Johnson & Johnson
- 3.14.1 Company Information
- 3.14.2 Product & Services
- 3.14.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.14.4 Recent Development
- 3.15 Merck & Co, Inc.
- 3.15.1 Company Information
- 3.15.2 Product & Services
- 3.15.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.15.4 Recent Development
- 3.16 BASF SE
- 3.16.1 Company Information
- 3.16.2 Product & Services
- 3.16.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.16.4 Recent Development
- 3.17 Catalent Inc.
- 3.17.1 Company Information
- 3.17.2 Product & Services
- 3.17.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.17.4 Recent Development
- 3.18 Teva Pharmaceuticals
- 3.18.1 Company Information
- 3.18.2 Product & Services
- 3.18.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.18.4 Recent Development
- 3.19 Roche
- 3.19.1 Company Information
- 3.19.2 Product & Services
- 3.19.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.19.4 Recent Development
- 3.20 Cambrex Corporation
- 3.20.1 Company Information
- 3.20.2 Product & Services
- 3.20.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
- 3.21 GILEAD Science Inc.
- 3.21.1 Company Information
- 3.21.2 Product & Services
- 3.21.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
- 4.1 Cardiovascular Diseases
- 4.1.1 Overview
- 4.1.2 Cardiovascular Diseases Market Size and Forecast
- 4.2 Respiratory Disorders
- 4.2.1 Overview
- 4.2.2 Respiratory Disorders Market Size and Forecast
- 4.3 Infectious Diseases
- 4.3.1 Overview
- 4.3.2 Infectious Diseases Market Size and Forecast
- 4.4 Others
- 4.4.1 Overview
- 4.4.2 Others Market Size and Forecast
5 Market by Type
5.By Standard API
- 5.1 Standard API
- 5.1.1 Overview
- 5.1.2 Standard API Market Size and Forecast
- 5.2 High Potency API
- 5.2.1 Overview
- 5.2.2 High Potency API Market Size and Forecast
6 Price Overview
- 6.1 Price by Manufacturers
- 6.2 Price by Application
- 6.3 Price by Type
7 Conclusion
Summary
The global Small Molecule Active Pharmaceutical Ingredient market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
Johnson Matthey
Siegfried Holding AG
Pfizer
Sanofi S.A.
Novartis AG,
Bristol-Myers Squibb
Boehringer Ingelheim GmbH
GlaxoSmithKline
Albany Molecular Research Inc.
Bachem Holding AG
PCAS
Patheon N.V.
AstraZeneca
Johnson & Johnson
Merck & Co, Inc.
BASF SE
Catalent Inc.
Teva Pharmaceuticals
Roche
Cambrex Corporation
GILEAD Science Inc.
Major applications as follows:
Cardiovascular Diseases
Respiratory Disorders
Infectious Diseases
Others
Major Type as follows:
Standard API
High Potency API
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa